US Supreme Court rules telehealth abortion can resume while lawsuit continues

The U.S. Supreme Court allowed telehealth access to abortion medication mifepristone to continue under current FDA rules while the U.S. 5th Circuit Court of Appeals decides the case Louisiana v. Food and Drug Administration. Justices Samuel Alito and Clarence Thomas dissented, with Thomas citing the Comstock Act as a legal basis to challenge the FDA's rule. Abortion-rights advocates welcomed the decision, while opponents criticized it as endangering patients.